New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

Today's Free Fly Stories
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | all day >>
07:47 EDTANNAnn Inc. reports Q1 Ann Taylor brand net sales $211.3M
Subscribe for More Information
07:46 EDTCONNConn's price target raised to $43 from $35 at Stifel
Subscribe for More Information
07:46 EDTANNAnn Inc. reports Q1 EPS excluding items 37c, consensus 33c
Reports Q1 revenue $597.73M, consensus $604.87M. The results reflected a weak February but positive comparable sales performance at both Ann Taylor and LOFT in the combined March and April period.
07:46 EDTMENTMentor Graphics reports Q1 adjusted EPS 28c, consensus 18c
Subscribe for More Information
07:45 EDTU.S. equities are on the rise
Subscribe for More Information
07:45 EDTN.Y. FX Outlook
N.Y. FX Outlook: The dollar pulled back some in London dealings, though has since rebounded, taking EUR-USD toward 1.1170 from 1.1208 highs. The earlier rally came on the back of better German Ifo data. USD-JPY is up flirting with 121 again, after falling back in Asia on a fairly benign BoJ meeting. USD-CAD has formed up over 1.2215, holding support at 1.2170. Canadian data will include retail sales and CPI, generally good for some CAD volatility. In the U.S., the sole release comes at 8:30 EDT in the form of April CPI.
07:44 EDTGPSGap turnaround timing remains uncertain, says UBS
Subscribe for More Information
07:44 EDTACTActavis trades at over 20% discount to Major Pharma, says JPMorgan
Subscribe for More Information
07:42 EDTHPQHP remains undervalued, says UBS
UBS believes HP shares remain undervalued and they view the stock as attractive based on the company's ultimate earnings power. The firm said Q2 results were not bad despite weakness in the PC hardware sector. UBS reiterated its Buy rating and $40 price target on HP shares.
07:40 EDTDHR, PLLDanaher price target raised to $94 from $80 at JPMorgan
Subscribe for More Information
07:40 EDTHPQHP should continue to be accumulated, says Brean Capital
Subscribe for More Information
07:39 EDTTFXTeleflex premium valuation justified, says Brean Capital
Brean Capital believes Teleflex deserves to trade at a premium following the company's analyst day. The firm cited the company strategy and long term financial goals, free cash flow growth expectations, and operating margin expansion potential. Brean Capital reiterated its Buy rating and raised its price target to $135 from $129 on Teleflex shares.
07:38 EDTSGYPSynergy Pharmaceuticals initiated with a Buy at Canaccord
Subscribe for More Information
07:38 EDTCHSChico's June volatility elevated into Q1 and outlook
Subscribe for More Information
07:38 EDTRWLKReWalk Robotics upgraded to Buy at Canaccord
As previously reported, Canaccord upgraded ReWalk Robotics to Buy from Hold. The firm believes the company is better positioned to experience improved sustainable growth. Canaccord raised its price target to $17 from $11 on ReWalk Robotics shares.
07:38 EDTBHPBHP Billiton downgraded to Market Perform from Outperform at BMO Capital
Subscribe for More Information
07:37 EDTARIAARIAD announces data presentations at EHA Congress
Subscribe for More Information
07:37 EDTSYNASynaptics price target raised to $105 from $95 at JPMorgan
JPMorgan raised its price target for Synaptics to $105 saying it is incrementally positive following the company's presentation at its conference. The firm believes Synaptics is executing well and reiterates an Overweight rating on the stock.
07:36 EDTNFLXNetflix price target raised to $700 at RBC Capital following customer surveys
Subscribe for More Information
07:33 EDTBMYBristol-Myers receives positive CHMP opinion for Nivolumab
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | all day >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use